- Home
- UIS vs CMRX Comparison
UIS vs CMRX Comparison
Compare UIS & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UIS
- CMRX
- Stock Information
- Founded
- UIS 1942
- CMRX 2000
- Country
- UIS United States
- CMRX United States
- Employees
- UIS N/A
- CMRX N/A
- Industry
- UIS EDP Services
- CMRX Biotechnology: Pharmaceutical Preparations
- Sector
- UIS Technology
- CMRX Health Care
- Exchange
- UIS Nasdaq
- CMRX Nasdaq
- Market Cap
- UIS 474.3M
- CMRX 394.1M
- IPO Year
- UIS N/A
- CMRX 2013
- Fundamental
- Price
- UIS $4.70
- CMRX $5.15
- Analyst Decision
- UIS Hold
- CMRX Strong Buy
- Analyst Count
- UIS 1
- CMRX 2
- Target Price
- UIS $6.50
- CMRX $8.50
- AVG Volume (30 Days)
- UIS 521.7K
- CMRX 1.7M
- Earning Date
- UIS 02-18-2025
- CMRX 03-07-2025
- Dividend Yield
- UIS N/A
- CMRX N/A
- EPS Growth
- UIS N/A
- CMRX N/A
- EPS
- UIS N/A
- CMRX N/A
- Revenue
- UIS $2,008,400,000.00
- CMRX $159,000.00
- Revenue This Year
- UIS $0.92
- CMRX N/A
- Revenue Next Year
- UIS $2.90
- CMRX $1,690.28
- P/E Ratio
- UIS N/A
- CMRX N/A
- Revenue Growth
- UIS N/A
- CMRX N/A
- 52 Week Low
- UIS $3.32
- CMRX $0.75
- 52 Week High
- UIS $8.93
- CMRX $5.53
- Technical
- Relative Strength Index (RSI)
- UIS 24.19
- CMRX 76.25
- Support Level
- UIS $6.66
- CMRX $3.94
- Resistance Level
- UIS $7.54
- CMRX $5.53
- Average True Range (ATR)
- UIS 0.43
- CMRX 0.30
- MACD
- UIS -0.22
- CMRX 0.07
- Stochastic Oscillator
- UIS 2.23
- CMRX 78.29
About UIS Unisys Corporation New
Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides solutions that transform digital workplaces securely and create exceptional end-user experiences. CA&I provides digital platform, applications and infrastructure solutions. ECS provides solutions that harness secure, continuous high-intensity computing and enable digital services through software-defined operating environments.
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.